BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22256468)

  • 1. Alcohol septal ablation without myocardial contrast echocardiography for hypertrophic obstructive cardiomyopathy.
    Chamnarnphol N; Wisaratapong T; Cheewatanakornkul S
    J Med Assoc Thai; 2011 Nov; 94(11):1299-303. PubMed ID: 22256468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy, the first cases series in Thailand.
    Chamnarnphol N; Wisaratapong T
    J Med Assoc Thai; 2008 Dec; 91(12):1801-5. PubMed ID: 19133512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
    Veselka J
    Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.
    Veselka J; Procházková S; Duchonová R; Bolomová-Homolová I; Pálenícková J; Tesar D; Cervinka P; Honek T
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):231-5. PubMed ID: 15390343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
    Klein N; Mende M; Hagendorff A; Neugebauer A; Pfeiffer D
    Dtsch Med Wochenschr; 2000 May; 125(19):579-83. PubMed ID: 11320715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M; Dokainish H; Lakkis N
    J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
    Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alcohol septal ablation and hypertrophic cardiomyopathy].
    Kimmelstiel C; Krishnamurthy B; Weintraub A; Kapur N
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1074-7. PubMed ID: 20193175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
    Seggewiss H; Faber L; Ziemssen P; Gleichmann U
    Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A repeat alcohol septal ablation procedure for hypertrophic obstructive cardiomyopathy where the first septal branch arose from the intermediate (ramus) artery.
    Doran GC; Burns CM; Murdoch DJ; Incani A; Walters DL
    Heart Lung Circ; 2013 Dec; 22(12):1026-9. PubMed ID: 23706939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
    Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
    Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy.
    Oto A; Aytemir K; Okutucu S; Kaya EB; Deniz A; Cil B; Peynircioglu B; Kabakci G
    J Interv Cardiol; 2011 Feb; 24(1):77-84. PubMed ID: 20973822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up.
    Durand E; Mousseaux E; Coste P; Pillière R; Dubourg O; Trinquart L; Chatellier G; Hagège A; Desnos M; Lafont A
    Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Safe and Apparently Efficacious But Does Reporting of Aggregate Outcomes Hide Less-Favorable Results, Experienced by a Substantial Proportion of Patients?
    Cooper RM; Shahzad A; McShane J; Stables RH
    J Invasive Cardiol; 2015 Jul; 27(7):301-8. PubMed ID: 26136275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation.
    Serber ER; Sears SF; Nielsen CD; Spencer WH; Smith KM
    Am J Cardiol; 2007 Nov; 100(10):1592-7. PubMed ID: 17996525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.